Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 24, 2024 - Issue 7
Submit an article Journal homepage
216
Views
0
CrossRef citations to date
0
Altmetric
Meta-analysis

Efficacy and safety of neoadjuvant therapy for HR-positive/HER2-negative early breast cancer: a Bayesian network meta-analysis

Ruiliang Chena Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China;b Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China;c Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian Province, ChinaORCID Iconhttps://orcid.org/0009-0004-5608-1273View further author information
ORCID Icon,
Yushuai Yuc Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian Province, China;d Department of Breast Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, ChinaView further author information
,
Jie Zhanga Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China;b Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China;c Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian Province, ChinaView further author information
,
Chuangui Songc Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian Province, China;d Department of Breast Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, ChinaView further author information
&
Chuan Wanga Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China;b Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China;c Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian Province, ChinaCorrespondence[email protected]
View further author information
Pages 599-611 | Received 20 Dec 2023, Accepted 25 Apr 2024, Published online: 17 May 2024

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.